LncRNA HOTAIR could mediate cisplatin resistance of HCC cells by regulating ABCB1 expression through STAT3 activation, identifying HOTAIR as a potential novel therapeutic target to reverse MDR in HCC [181]. Here, HOTAIR is linked to hepatocellular carcinoma.